-
Matthew H LiangHarvard Medical SchoolUSA
-
MATTHEW H. LIANG, MD, FACP, FACR, MACR
Professor of Medicine, Harvard Medical School
Professor of Health Policy and Management, Harvard T.H. Chan School of Public Health
Trained in medicine, tropical public health, epidemiology, health services research, and rheumatology, he was recruited to Harvard in 1977 to build a program in population sciences. He has mentored over 76 clinician-scientists from 7 countries. Eighteen are now professors. Many have become leaders in their own right and recognized by major awards in a variety of fields.
His group has contributed to the understanding of the causes and social determinants of outcome in rheumatic disease, improving health equity, and to the basic methods clinical research in arthritis and musculoskeletal diseases.
His group demonstrated that oral contraceptives and hormone replacement therapy were risk factors for developing SLE, that silicone breast implants did not cause connective tissue disease, that anti-phospholipid antibody was a risk factor for blood clots in men. His group documented the long-term consequences of Lyme disease in a defined geographical area, the barriers to preventive behaviors, and showed that Lyme Disease could be prevented by targeted health education. His team developed the first patient-oriented burn outcome measures which is now the standard for outcomes benchmarking. In 2004, he rebuilt the VA Section of Rheumatology and in the VA Cooperative Studies Program, the world’s largest, oldest investigator-initiated trials program, completed trials in schizophrenia and suicide prevention. US Patent No 6,576,256 is for a “polypill” of a statin, ACE inhibitor, and aspirin. Various instruments developed including SLAM, SLAM-R, CSQ are freely available for the public.
He is currently on the Advisory Boards of the Institute for Rheumatology Research of Hanyang University, the Hiller Research Center for Rheumatology of Heinrich Heine University Düsseldorf, the VA Geriatric Research Education and Clinical Center , the Dean’s Advisory Council on Education of Harvard Medical School. He has been a consultant/advisor to the US Food and Drug Administration, Social Security Administration, Value Rx, Institute for Clinical and Economic Review, the NIH, NIAMS, Research Grants Council of Hong Kong, Rx Foundation, and the China Medical Board.
Dr. Liang is recipient of the Lawrence Poole Prize in Rehabilitation (University of Edinburgh), the Lee C. Howley Sr Prize for Research in Arthritis, the American College of Rheumatology Award of Distinction for Clinical Research, the Kirkland Scholar Award, the Molson Foundation Scholar Award, the Wallace Epstein Award for Training in Clinical Research, the Marian Ropes Lifetime Achievement Award, and a Master of the American College of Rheumatology. A chair in his honor is endowed at the Brigham and Women’s Hospital.” [402 words]
http://connects.catalyst.harvard.edu/profiles/profile/person/33041
https://openpaymentsdata.cms.gov/physician/1194604
https://en.wikipedia.org/wiki/Matthew_H._LiangResearch & Clinical Focushealth disparities, clinical epidemiology, health services research, SLE
| Date | Time | Room | Session Title | Lecture Title |
|---|---|---|---|---|
| May 19 | 13:40-14:00 | Room Grand Ballroom 102 | [Alliance Session 3] Global Collaboration to Overcome Health Care Disparities | Strategies to end health disparities in SLE |
